Eisai Co - Company & Market Research Reports

Home /
Companies /
Eisai Co

Eisai Limited is a research-based pharmaceutical company that develops, manufactures, and markets healthcare products for patients and their families. It offers products in the areas of Alzheimer's disease, gastrointestinal disorders, epilepsy, cervical dystonia, severe chronic pain, and oncology. The company was founded in 1988 and is based in Hatfield, United Kingdom. It also has operations in the United States, Asia, and Europe.

REFINE BY

KEYWORD

CATEGORIES

Central Nervous System Drugs 118
Oncology Drugs 117
Drug Discovery 65
Gastrointestinal Drugs 53
Clinical Trials 32
Alzheimer's Disease Drugs 30
Musculoskeletal Disorders Drugs 29
Pharmaceuticals 28
Liver Cancer Drugs 27
Cardiovascular Drugs 21
Infectious Diseases Drugs 21
Brain Cancer Drugs 21
Immune Disorders Drugs 20
Leukemia Drugs 18
Biopharmaceuticals 18
Breast Cancer Drugs 16
Lymphoma Drugs 15
Skin Cancer Drugs 12
Kidney Cancer Drugs 12
Endocrine and Metabolic Disorders Drugs 12
Drugs by Therapeutic Area 11
Anesthetic Drugs 11
Infusions and Injectables 10
Liver and Kidney Disorders Drugs 10
Drug Delivery 9
Colon Cancer Drugs 8
Analgesics 8
Hematological Drugs 8
Thyroid Cancer Drugs 8
Pharmaceutical Manufacturing 8
Lung Cancer Drugs 7
Uterine Cancer Drugs 7
Anti-Obesity Drugs 7
Ovarian Cancer Drugs 6
Bladder Cancer Drugs 6
Over the Counter (OTC) Drugs 6
Vitamins and Dietary Supplements 6
Respiratory Drugs 5
Company Reports 4
Optical Disorders Drugs 4
Mental Disorders Drugs 4
Dermatological Drugs 4
Pharmaceutical Intermediates 3
Cervical Cancer Drugs 3
Prostate Cancer Drugs 2
Biosimilars and Biosuperiors 2
Pancreatic Cancer Drugs 2
Sexual and Reproductive Health Drugs 2
Diabetes Drugs 1
Generic Drugs 1
Pharmacoeconomics 1
Vaccines 1
Psoriasis Drugs 1
Immunosuppressive Drugs 1

SHOW ALL

REPORT TYPE

All Reports

Company Reports

Market Reports

Google Reviews

4.8



276 reviews

683 Results (Page 7 of 35)
- Relevance
  Sort by

Small-Cell Lung Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
November 2022
574 Pages
Global

From

€2469EUR$2,500USD£2,054GBP

Endometrial Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
October 2022
532 Pages
Global

From

€2469EUR$2,500USD£2,054GBP

Prostate Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
November 2022
1663 Pages
Global

From

€2469EUR$2,500USD£2,054GBP

Alzheimer's Disease Therapeutics Market Forecast - Epidemiology & Pipeline Analysis 2023-2028

 Report
February 2023
244 Pages
Global

From

€4148EUR$4,200USD£3,451GBP

Chemotherapy Induced Nausea And Vomiting Treatment Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2022 To 2030

 Report
August 2022
120 Pages
Global

From

€4444EUR$4,500USD£3,698GBP

NEED HELP FINDING THE RIGHT PRODUCT? Francesca will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

Melanoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
November 2022
1699 Pages
Global

From

€2469EUR$2,500USD£2,054GBP

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
December 2022
1560 Pages
Global

From

€2469EUR$2,500USD£2,054GBP

Neurology Clinical Trials Market Report and Forecast 2024-2032

 Report
October 2023
140 Pages
Global

From

€2962EUR$2,999USD£2,464GBP

Global Esophageal Squamous Cell Carcinoma - Pipeline Insight, 2022

 Clinical Trials
August 2022
150 Pages
Global

From

€1728EUR$1,750USD£1,438GBP

€2469EUR$2,500USD£2,054GBP

Acute Pancreatitis - Pipeline Insight, 2024

 Clinical Trials
August 2024
60 Pages
Global

From

€864EUR$875USD£719GBP

€1235EUR$1,250USD£1,027GBP

Kidney Cancer Drugs - Global Strategic Business Report

 Report
November 2024
148 Pages
Global

From

€5383EUR$5,450USD£4,478GBP

Alzheimer's Disease Drugs - Global Strategic Business Report

 Report
November 2024
93 Pages
Global

From

€5531EUR$5,600USD£4,602GBP

Advanced Renal Cell Carcinoma Therapeutics Global Market Insights 2022, Analysis and Forecast to 2027, by Manufacturers, Regions, Technology, Application, Product Type

 Report
March 2022
99 Pages
Global

From

€3500EUR$3,796USD£3,014GBP

Cervical Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
October 2022
700 Pages
Global

From

€2469EUR$2,500USD£2,054GBP

Sleep Aids Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

 Report
June 2022
120 Pages
Global

From

€4691EUR$4,750USD£3,903GBP

Anti-Migraine Drugs Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type

 Report
July 2024
99 Pages
Global

From

€3500EUR$3,796USD£3,014GBP

Alzheimer's Therapeutics Market Size, Share & Trends Analysis By Product (Cholinesterase Inhibitors, NMDA Receptor Antagonist, Combination Drug, Pipeline Drugs), By End-user, By Region, And Segment Forecasts, 2023-2030

 Report
June 2023
103 Pages
Global

From

€5877EUR$5,950USD£4,889GBP

Voltage-Dependent T-Type Calcium Channel Blockers - Pipeline Insight, 2024

 Clinical Trials
January 2024
60 Pages
Global

From

€864EUR$875USD£719GBP

€1235EUR$1,250USD£1,027GBP

Fallopian Tube Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
August 2022
871 Pages
Global

From

€2469EUR$2,500USD£2,054GBP

United States Endometrial Cancer Market, Competition, Forecast and Opportunities, 2018-2028

 Report
October 2023
90 Pages
United States

From

€3457EUR$3,500USD£2,876GBP

683 Results (Page 7 of 35)
- 1
- 5
- 6
- 7
- 8
- 9

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.